134 related articles for article (PubMed ID: 24103524)
1. CD24 and Nanog identify stem cells signature of ovarian epithelium and cysts that may develop to ovarian cancer.
Schreiber L; Raanan C; Amsterdam A
Acta Histochem; 2014 Mar; 116(2):399-406. PubMed ID: 24103524
[TBL] [Abstract][Full Text] [Related]
2. Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship.
Amsterdam A; Raanan C; Schreiber L; Freyhan O; Schechtman L; Givol D
Acta Histochem; 2013 May; 115(4):330-8. PubMed ID: 23092806
[TBL] [Abstract][Full Text] [Related]
3. Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.
Virant-Klun I; Kenda-Suster N; Smrkolj S
J Ovarian Res; 2016 Mar; 9():12. PubMed ID: 26940129
[TBL] [Abstract][Full Text] [Related]
4. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
Auersperg N
Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours.
Nagare RP; Sneha S; Sidhanth C; Roopa S; Murhekar K; Shirley S; Swaminathan R; Sridevi V; Ganesan TS
Cancer Biomark; 2020; 28(3):397-408. PubMed ID: 32224528
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell-Related Marker NANOG Expression in Ovarian Serous Tumors: A Clinicopathological Study of 159 Cases.
Kenda Šuster N; Frković Grazio S; Virant-Klun I; Verdenik I; Smrkolj Š
Int J Gynecol Cancer; 2017 Nov; 27(9):2006-2013. PubMed ID: 28906309
[TBL] [Abstract][Full Text] [Related]
7. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells.
Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E; Givol D
Acta Histochem; 2013 May; 115(4):320-9. PubMed ID: 23098761
[TBL] [Abstract][Full Text] [Related]
9. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
Banet N; Kurman RJ
Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
[TBL] [Abstract][Full Text] [Related]
10. Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.
Pan Y; Jiao J; Zhou C; Cheng Q; Hu Y; Chen H
Pathobiology; 2010; 77(6):283-8. PubMed ID: 21266826
[TBL] [Abstract][Full Text] [Related]
11. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology.
Okamura H; Katabuchi H; Nitta M; Ohtake H
Microsc Res Tech; 2006 Jun; 69(6):469-81. PubMed ID: 16718660
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.
Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT
Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
14. CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.
Burgos-Ojeda D; Wu R; McLean K; Chen YC; Talpaz M; Yoon E; Cho KR; Buckanovich RJ
Mol Cancer Ther; 2015 Jul; 14(7):1717-27. PubMed ID: 25969154
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.
Moulla A; Miliaras D; Sioga A; Kaidoglou A; Economou L
Pol J Pathol; 2013 Oct; 64(3):180-4. PubMed ID: 24166603
[TBL] [Abstract][Full Text] [Related]
16. Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.
Horiuchi A; Itoh K; Shimizu M; Nakai I; Yamazaki T; Kimura K; Suzuki A; Shiozawa I; Ueda N; Konishi I
Gynecol Oncol; 2003 Mar; 88(3):309-17. PubMed ID: 12648580
[TBL] [Abstract][Full Text] [Related]
17. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
18. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
Mishra S; Tiwari V; Arora A; Gupta S; Anand N; Husain N
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2539-2547. PubMed ID: 32986350
[TBL] [Abstract][Full Text] [Related]
20. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
Okamura H; Katabuchi H
Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
